Vertex to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8

Rhea-AI Summary

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) CEO to Present at J.P. Morgan Healthcare Conference

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 42^nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 11:15 a.m. ET/8:15 a.m. PT.

A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including APOL1-mediated kidney disease, acute and neuropathic pain, type 1 diabetes and alpha-1 antitrypsin deficiency.

Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 14 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on LinkedIn, Facebook, Instagram, YouTube and Twitter/X.

(VRTX-WEB)

View source version on businesswire.com: https://www.businesswire.com/news/home/20231218786603/en/

Vertex Pharmaceuticals Incorporated Investor Relations:

InvestorInfo@vrtx.com

Source: Vertex Pharmaceuticals Incorporated

FAQ

When will Dr. Reshma Kewalramani, CEO of Vertex Pharmaceuticals (Nasdaq: VRTX), present at the J.P. Morgan Healthcare Conference?

Dr. Reshma Kewalramani will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 11:15 a.m. ET/8:15 a.m. PT.

Where can I watch the live webcast of the conference?

The live webcast will be available through the Vertex website, www.vrtx.com, in the 'Investors' section under the 'News and Events' page.

Will there be a replay of the conference webcast available?

Yes, a replay of the conference webcast will be archived on the company's website.